Quantum Biopharma (QNTM) EPS (Weighted Average and Diluted) (2019 - 2026)
Quantum Biopharma recorded quarterly EPS (Weighted Average and Diluted) of -$4.43 in Q1 2026, down 475.21% quarter-over-quarter from -$0.77 in Q4 2025, and down 82.39% year-over-year from -$25.16 in Q1 2025.
Quantum Biopharma's EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at -$4.43 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 82.39% year-over-year to -$4.43; the TTM figure through Mar 2026 stood at -$4.43 (down 82.39% YoY), while the FY2025 annual figure was -$4.71, changed N/A from the prior year.
- EPS (Weighted Average and Diluted) came in at -$4.43 for Q1 2026 at Quantum Biopharma, down from -$0.77 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.0 in Q1 2022 to a low of -$23.94 in Q2 2024.
- A 5-year average of -$4.06 and a median of -$0.74 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) slumped 217132247.96% in 2024 and soared 94.26% in 2025, its largest moves.
- Quantum Biopharma's EPS (Weighted Average and Diluted) stood at -$0.0 in 2022, then tumbled by 351009573.62% to -$0.04 in 2023, then tumbled by 787.1% to -$0.35 in 2024, then tumbled by 122.64% to -$0.77 in 2025, then slumped by 475.21% to -$4.43 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$4.43, -$0.77, and -$0.71 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -2.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.43 |
| Dec 31, 2025 | -0.70 |
| Sep 30, 2025 | -0.71 |
| Jun 30, 2025 | -1.37 |
| Mar 31, 2025 | -2.43 |
| Sep 30, 2024 | -0.35 |
| Jun 30, 2024 | -23.94 |
| Mar 31, 2024 | -0.55 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -14.08 |
| Mar 31, 2023 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2019 | -2.17 |